Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C‐pe...

por Fujioka, Youhei, Okura, Tsuyoshi, Sumi, Keisuke, Matsumoto, Kazuhisa, Shoji, Kyoko, Nakamura, Risa, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Kato, Masahiko, Taniguchi, Shinichi, Yamamoto, Kazuhiro
Publicado 2017

High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report

por Okura, Tsuyoshi, Ueta, Etsuko, Nakamura, Risa, Fujioka, Yohei, Sumi, Keisuke, Matsumoto, Kazuhisa, Shoji, Kyoko, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Nomi, Yuri, Mihara, Hitomi, Otsuka, Yuzuru, Kato, Masahiko, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Publicado 2017

CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance—A preliminary research

por Okura, Tsuyoshi, Nakamura, Risa, Fujioka, Yohei, Kawamoto-Kitao, Sonoko, Ito, Yuichi, Matsumoto, Kazuhisa, Shoji, Kyoko, Sumi, Keisuke, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Publicado 2018

Body mass index ≥23 is a risk factor for insulin resistance and diabetes in Japanese people: A brief report

por Okura, Tsuyoshi, Nakamura, Risa, Fujioka, Yohei, Kawamoto-Kitao, Sonoko, Ito, Yuichi, Matsumoto, Kazuhisa, Shoji, Kyoko, Sumi, Keisuke, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Publicado 2018

The sodium–glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes

por Okura, Tsuyoshi, Fujioka, Yohei, Nakamura, Risa, Kitao, Sonoko, Ito, Yuichi, Anno, Mari, Matsumoto, Kazuhisa, Shoji, Kyoko, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Okura, Hiroko, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Publicado 2022

Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report

por Okura, Tsuyoshi, Fujioka, Yohei, Nakamura, Risa, Ito, Yuichi, Kitao, Sonoko, Anno, Mari, Matsumoto, Kazuhisa, Shoji, Kyoko, Okura, Hiroko, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Publicado 2022

Aldehyde dehydrogenase 2 polymorphism is an important gene for insulin resistance in Japanese patients with type 2 diabetes

por Okura, Tsuyoshi, Nakamura, Risa, Anno, Mari, Ito, Yuichi, Kitao, Sonoko, Endo, Satomi, Taneda, Natsuka, Matsumoto, Kazuhisa, Shoji, Kyoko, Okura, Hiroko, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Publicado 2023

Significance of pancreatic duodenal homeobox-1 (PDX-1) genetic polymorphism in insulin secretion in Japanese patients with type 2 diabetes

por Okura, Tsuyoshi, Nakamura, Risa, Ito, Yuichi, Kitao, Sonoko, Anno, Mari, Endo, Satomi, Taneda, Natsuka, Matsumoto, Kazuhisa, Shoji, Kyoko, Okura, Hiroko, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Ueta, Etsuko, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Publicado 2022

Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report

por Okura, Tsuyoshi, Fujioka, Yohei, Nakamura, Risa, Anno, Mari, Ito, Yuichi, Kitao, Sonoko, Matsumoto, Kazuhisa, Shoji, Kyoko, Sumi, Keisuke, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Okura, Hiroko, Ueta, Etsuko, Noma, Hisashi, Kato, Masahiko, Imamura, Takeshi, Taniguchi, Shin-Ichi, Yamamoto, Kazuhiro
Publicado 2020